Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
7.12
0.78 (12.30%)
At close: Jun 23, 2025, 3:59 PM
7.60
6.74%
After-hours: Jun 23, 2025, 07:59 PM EDT
12.30%
Bid 6.98
Market Cap 858.88M
Revenue (ttm) n/a
Net Income (ttm) -15.2M
EPS (ttm) -0.56
PE Ratio (ttm) -12.71
Forward PE 3.93
Analyst Buy
Ask 7.6
Volume 1,797,229
Avg. Volume (20D) 342,205
Open 6.22
Previous Close 6.34
Day's Range 5.90 - 8.25
52-Week Range 2.02 - 11.00
Beta 2.00

About UNCY

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
-8.89%
Unicycive Therapeutics shares are trading lower af... Unlock content with Pro Subscription
2 weeks ago
-40.89%
Unicycive Therapeutics shares are trading lower after the company announced update on its New Drug Application for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease on dialysis.